Another neurotrophic factor, nerve growth factor (NGF), showed no significant adverse effects in a topical preparation administered to RP patients, and a minority of patients reported subjective visual benefits in a pilot trial [30]. Here, NGF is linked to retinitis pigmentosa 1.